Gross Total Resection and Survival Outcomes in Elderly Patients with Spinal Chordoma: a SEER-based Analysis

Overview

Journal Front Oncol

Specialty Oncology

Date 2024 Feb 14

PMID 38352297

Authors

John Pham

Elias Shaaya

Ben Rhee

Anna Kimata

Evrim E Ozcan

Katie M Pham

Tianyi Niu

Patricia Sullivan

Ziya L Gokaslan

Affiliations

Soon will be listed here.

Abstract

Objective: The association between aggressive resection and improved survival for adult spinal chordoma patients has not been well characterized in the geriatric population. Thus, the present study aimed to elucidate the relationship between gross total resection (GTR) and survival outcomes for patients across different age groups.

Methods: The authors isolated all adult patients diagnosed with spinal chordoma from the 2000-2019 Surveillance, Epidemiology, and End Results database and divided patients into three surgical subgroups: no surgery, subtotal resection (STR), and GTR. Kaplan-Meier curves with a log-rank test were used to discern differences in overall survival (OS) between surgical subgroups. Univariate and multivariate analyses were used to identify prognostic factors of mortality.

Results: There were 771 eligible patients: 227 (29.4%) received no surgery, 267 (34.6%) received STR, and 277 (35.9%) received GTR. Patients receiving no surgery had the lowest 5-year OS (45.2%), 10-year OS (17.6%), and mean OS (72.1 months). After stratifying patients by age, our multivariate analysis demonstrated that patients receiving GTR aged 40-59 (HR=0.26, CI=0.12-0.55, p<0.001), 60-79 (HR=0.51, CI=0.32-0.82, p=0.005), and 80-99 (HR=0.14, CI=0.05-0.37, p<0.001) had a lower risk of mortality compared to patients undergoing no surgery. The frequency of receiving GTR also decreased as a function of age (16.4% [80-99 years] vs. 43.2% [20-39 years]; p<0.001), but the frequency of receiving radiotherapy was comparable across all age groups (48.3% [80-99 years] vs. 45.5% [20-39 years]; p=0.762).

Conclusion: GTR is associated with improved survival for middle-aged and elderly patients with spinal chordoma. Therefore, patients should not be excluded from aggressive resection on the basis of age alone. Rather, the decision to pursue surgery should be decided on an individual basis.

References

Capo G, Moiraghi A, Baro V, Tahhan N, Delaidelli A, Saladino A . Surgical Treatment of Spinal Meningiomas in the Elderly (≥75 Years): Which Factors Affect the Neurological Outcome? An International Multicentric Study of 72 Cases. Cancers (Basel). 2022; 14(19). PMC: 9563730. DOI: 10.3390/cancers14194790. View

Mukherjee D, Chaichana K, Ziya L Gokaslan , Aaronson O, Cheng J, McGirt M . Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003. J Neurosurg Spine. 2010; 14(2):143-50. DOI: 10.3171/2010.10.SPINE10189. View

McIntyre A, Song Z . The US Affordable Care Act: Reflections and directions at the close of a decade. PLoS Med. 2019; 16(2):e1002752. PMC: 6390990. DOI: 10.1371/journal.pmed.1002752. View

Fontes R, OToole J . Chordoma of the thoracic spine in an 89-year-old. Eur Spine J. 2011; 21 Suppl 4:S428-32. PMC: 3369041. DOI: 10.1007/s00586-011-1980-6. View

Stacchiotti S, Casali P, Lo Vullo S, Mariani L, Palassini E, Mercuri M . Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol. 2009; 17(1):211-9. DOI: 10.1245/s10434-009-0740-x. View

Yu E, Koffer P, DiPetrillo T, Kinsella T . Incidence, Treatment, and Survival Patterns for Sacral Chordoma in the United States, 1974-2011. Front Oncol. 2016; 6:203. PMC: 5018685. DOI: 10.3389/fonc.2016.00203. View

Pennicooke B, Laufer I, Sahgal A, Varga P, Ziya L Gokaslan , Bilsky M . Safety and Local Control of Radiation Therapy for Chordoma of the Spine and Sacrum: A Systematic Review. Spine (Phila Pa 1976). 2016; 41 Suppl 20:S186-S192. PMC: 5572655. DOI: 10.1097/BRS.0000000000001831. View

Wang M, Green B, Shah S, Vanni S, Levi A . Complications associated with lumbar stenosis surgery in patients older than 75 years of age. Neurosurg Focus. 2005; 14(2):e7. DOI: 10.3171/foc.2003.14.2.8. View

Yamada Y, Gounder M, Laufer I . Multidisciplinary management of recurrent chordomas. Curr Treat Options Oncol. 2013; 14(3):442-53. DOI: 10.1007/s11864-013-0247-3. View

10.

Yamada Y, Laufer I, Cox B, Lovelock D, Maki R, Zatcky J . Preliminary results of high-dose single-fraction radiotherapy for the management of chordomas of the spine and sacrum. Neurosurgery. 2013; 73(4):673-80. DOI: 10.1227/NEU.0000000000000083. View

11.

Fisher C, Saravanja D, Dvorak M, Rampersaud Y, Clarkson P, Hurlbert J . Surgical management of primary bone tumors of the spine: validation of an approach to enhance cure and reduce local recurrence. Spine (Phila Pa 1976). 2010; 36(10):830-6. DOI: 10.1097/BRS.0b013e3181e502e5. View

12.

Lockney D, Shub T, Hopkins B, Lockney N, Moussazadeh N, Lis E . Spinal stereotactic body radiotherapy following intralesional curettage with separation surgery for initial or salvage chordoma treatment. Neurosurg Focus. 2017; 42(1):E4. DOI: 10.3171/2016.9.FOCUS16373. View

13.

Passer J, Alvarez-Breckenridge C, Rhines L, DeMonte F, Tatsui C, Raza S . Surgical Management of Skull Base and Spine Chordomas. Curr Treat Options Oncol. 2021; 22(5):40. DOI: 10.1007/s11864-021-00838-z. View

14.

Moran D, Zadnik P, Taylor T, Groves M, Yurter A, Wolinsky J . Maintenance of bowel, bladder, and motor functions after sacrectomy. Spine J. 2014; 15(2):222-9. DOI: 10.1016/j.spinee.2014.08.445. View

15.

Huang J, Chen D, Sang C, Zheng X, Lin J, Lin Y . Nomogram for Individualized Prediction and Prognostic Factors for Survival in Patients with Primary Spinal Chordoma: A Population-Based Longitudinal Cohort Study. World Neurosurg. 2019; 128:e603-e614. DOI: 10.1016/j.wneu.2019.04.217. View

16.

Ziya L Gokaslan , Zadnik P, Sciubba D, Germscheid N, Goodwin C, Wolinsky J . Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database. J Neurosurg Spine. 2015; 24(4):644-51. PMC: 4818185. DOI: 10.3171/2015.7.SPINE15201. View

17.

McMaster M, Goldstein A, Bromley C, Ishibe N, Parry D . Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control. 2001; 12(1):1-11. DOI: 10.1023/a:1008947301735. View

18.

Tome-Bermejo F, Pinera A, Alvarez-Galovich L . Osteoporosis and the Management of Spinal Degenerative Disease (I). Arch Bone Jt Surg. 2017; 5(5):272-282. PMC: 5712392. View

19.

Fuchs B, Dickey I, Yaszemski M, Inwards C, Sim F . Operative management of sacral chordoma. J Bone Joint Surg Am. 2005; 87(10):2211-6. DOI: 10.2106/JBJS.D.02693. View

20.

Stacchiotti S, Sommer J . Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol. 2015; 16(2):e71-83. DOI: 10.1016/S1470-2045(14)71190-8. View